Skip to main content
    I

    ICU Medical Inc (ICUI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $162.69
    -0.54 (-0.33%)

    Market Cap: $4.08B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    92%(36/39)
    Avg Surprise
    +31.04%
    Streak
    16 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.15
    Range$2.12 - $2.19
    7 analysts
    EPS Revisions
    6
    0
    7d
    6
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$2.08+3.2%
    60d ago$2.08+3.1%
    30d ago$2.150.0%
    7d ago$2.150.0%
    Current$2.15
    Revenue Consensus
    $554M
    Range$550M - $567M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.94
    Range$2.83 - $3.02
    8 analysts
    Revenue Consensus
    $571M
    Range$559M - $595M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.94---
    Sep 26EST
    		-$2.15---
    Jun 26
    Reported Aug 6
    		$2.01$1.49+34.90%Beat+21.1%
    Mar 26
    Reported May 7
    		$1.97$1.75+12.57%Beat+14.5%
    Dec 25
    Reported Feb 19
    		$1.91$1.69+13.02%Beat-9.5%
    Sep 25
    Reported Nov 6
    		$2.03$1.43+41.96%Beat+27.7%
    Jun 25
    Reported Aug 7
    		$1.66$1.14+45.61%Beat+6.4%
    Mar 25
    Reported May 8
    		$1.72$1.28+34.38%Beat+79.2%
    Dec 24
    Reported Feb 27
    		$2.11$1.48+42.38%Beat+34.4%
    Sep 24
    Reported Nov 12
    		$1.59$1.25+27.20%Beat+1.3%
    Jun 24
    Reported Aug 7
    		$1.56$1.00+56.00%Beat-17.0%
    Mar 24
    Reported May 7
    		$0.96$0.82+17.07%Beat-44.8%
    Dec 23
    Reported Feb 27
    		$1.57$1.19+31.93%Beat-1.9%
    Sep 23
    Reported Nov 6
    		$1.57$1.39+12.95%Beat-10.3%
    Jun 23
    Reported Aug 7
    		$1.88$1.60+17.50%Beat+37.2%
    Mar 23
    Reported May 8
    		$1.74$1.43+21.68%Beat-4.4%
    Dec 22
    Reported Feb 27
    		$1.60$1.56+2.56%Beat-12.1%
    Sep 22
    Reported Nov 7
    		$1.75$1.46+19.86%Beat-15.5%
    Jun 22
    Reported Aug 8
    		$1.37$1.66-17.47%Miss-27.1%
    Mar 22
    Reported May 9
    		$1.82$1.78+2.25%Beat+12.3%
    Dec 21
    Reported Feb 24
    		$1.82$1.64+10.98%Beat+2.8%
    Sep 21
    Reported Nov 3
    		$2.07$1.80+15.00%Beat+8.9%
    Jun 21
    Reported Aug 4
    		$1.88$1.64+14.63%Beat+13.9%
    Mar 21
    Reported May 6
    		$1.62$1.50+8.00%Beat-10.5%
    Dec 20
    Reported Feb 25
    		$1.77$1.51+17.22%Beat-8.8%
    Sep 20
    Reported Nov 5
    		$1.90$1.31+45.04%Beat+15.2%
    Jun 20
    Reported Aug 10
    		$1.65$1.24+33.06%Beat-17.1%
    Mar 20
    Reported May 7
    		$1.81$1.63+11.04%Beat-29.8%
    Dec 19
    Reported Feb 27
    		$1.94$1.66+16.87%Beat-6.3%
    Sep 19
    Reported Nov 11
    		$1.65$1.62+1.85%Beat-10.8%
    Jun 19
    Reported Aug 7
    		$1.99$2.06-3.40%Miss-25.2%
    Mar 19
    Reported May 9
    		$2.58$2.17+18.89%Beat+14.2%
    Dec 18
    Reported Feb 28
    		$2.07$1.80+15.00%Beat-30.5%
    Sep 18
    Reported Nov 8
    		$1.85$1.51+22.52%Beat+65.2%
    Jun 18
    Reported Aug 9
    		$2.66$1.82+46.15%Beat+250.0%
    Mar 18
    Reported May 9
    		$2.26$1.84+22.83%Beat+34.5%
    Dec 17
    Reported Mar 1
    		$2.98$1.04+186.54%Beat+148.3%
    Sep 17
    Reported Nov 9
    		$1.12$0.76+47.37%Beat-
    Jun 17
    Reported Aug 9
    		$0.76$0.77-1.30%Miss-
    Mar 17
    Reported May 10
    		$1.68$0.46+265.22%Beat-
    Dec 16
    Reported Mar 1
    		$1.20$1.19+0.84%Beat-

    Key Metrics

    Valuation
    P/E Ratio20.54EV/EBITDA17.43x
    Price/FCF26.61xFCF Yield3.76%
    Profitability
    Profit Margin1.39%Operating Margin7.53%
    ROE1.41%ROIC2.17%
    Financial Health
    Debt/Equity0.57xInterest Coverage1.01x
    Current Ratio2.43xQuick Ratio1.21x
    Trading Statistics
    Beta0.86Avg Volume250.28K
    52-Week High$192.8552-Week Low$113.37

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$160.10
    SMA 20$160.25
    SMA 50$167.96
    SMA 200$147.57
    EMA 10$161.16
    EMA 20$161.44
    EMA 50$162.31
    EMA 200$150.75

    MACD

    Line: -0.87Signal: -1.62Hist: 0.75

    ADX

    ADX: 14.6+DI: 26.5-DI: 21.1

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down28.0
    PSAR$153.60

    Bollinger Bands

    Upper Band$168.12
    Lower Band$152.39
    %B Position982%(Upper)
    Band Width0.65

    RSI (14-Day)

    Neutral
    51.2

    Momentum Oscillators

    Stoch %K70.3
    Stoch %D61.8
    Williams %R-31.8
    ROC (10d)1.4%
    Momentum2.18
    CCI (20d)54.2
    MFI (14d)31.6

    Volatility Measures

    ATR (14d)$4.37(2.7%)
    StdDev (20d)3.93
    Hist Vol26.2%(Moderate)

    Volume Flow

    VWAP$162.79
    OBV-487.2K
    AD Line-2.5M
    CMF (20d)-0.031

    Volume Metrics

    Avg Vol (20d)255.8K
    Vol Ratio1.0x
    VWMA (20d)$160.37

    Pivot Points

    R3$169.92
    R2$168.48
    R1$165.86
    Pivot Point$164.42
    S1$161.80
    S2$160.36
    S3$157.74

    Advanced Oscillators

    TSI-5.94
    Ultimate Osc49.6
    KST-38.42

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$551.68M$530.23M$540.70M$536.99M$548.87M$604.70M$629.80M$589.13M$596.46M$566.65M$587.86M$553.31M
    Cost of Revenue$316.63M$324.00M$337.72M$336.11M$340.80M$394.59M$402.55M$384.28M$389.03M$381.41M$416.27M$369.39M
    Gross Profit$235.05M$206.23M$202.99M$200.88M$208.06M$210.11M$227.26M$204.85M$207.43M$185.24M$171.59M$183.92M
    Operating Expenses$195.93M$192.65M$197.35M$187.16M$197.48M$197.22M$189.57M$196.62M$199.74M$195.90M$183.77M$161.07M
    R&D$22.70M$21.28M$21.09M$21.25M$21.87M$23.29M$22.36M$21.03M$23.39M$21.84M$22.41M$20.87M
    SG&A$151.92M$154.57M$155.81M$152.77M$159.39M$157.23M$158.85M$162.71M$159.55M$157.66M$154.62M$148.61M
    Operating Income$39.13M$13.58M$5.63M$13.72M$10.59M$12.89M$37.69M$8.24M$7.69M$-10,655,000$-12,183,000$22.85M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$15.75M$16.49M$20.64M$19.81M$20.55M$22.03M$23.46M$24.68M$23.84M$23.77M$24.41M$24.18M
    Income Before Tax$23.14M$-3,975,000$-15,902,000$-2,513,000$33.68M$-10,906,000$8.22M$-17,928,000$-19,533,000$-36,768,000$-36,681,000$-5,366,000
    Income Tax Expense$7.07M$-34,714,000$-2,653,000$-658,000$1.18M$4.57M$32.05M$15.05M$1.87M$2.70M$-19,534,000$-12,604,000
    Net Income$19.09M$30.13M$-15,734,000$-3,396,000$35.34M$-15,476,000$-23,828,000$-32,983,000$-21,406,000$-39,471,000$-17,147,000$7.24M
    EBITDA$85.13M$67.49M$60.15M$74.16M$101.20M$66.75M$91.70M$69.61M$66.51M$49.58M$51.96M$84.32M
    EBIT$38.89M$12.52M$4.74M$17.30M$54.23M$11.13M$31.67M$6.75M$4.31M$-12,996,000$-12,273,000$18.81M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ICUI

    Government Contracts

    Gov Obligations (TTM)
    -$14474
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    4
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    ICUI Valuation and Fair Value

    P/E
    20.5x
    Forward P/E
    16.9x
    EV/EBITDA
    17.4x
    P/FCF
    26.6x
    PEG
    0.1x
    P/B
    1.9x
    See GNG's fair value

    ICUI Profitability: Margins, ROIC and FCF

    Gross margin
    39.1%
    Operating margin
    7.5%
    Net margin
    1.4%
    ROIC
    2.2%
    ROE
    1.4%
    FCF margin
    7.1%
    FCF yield
    3.8%

    ICUI Competitors

    CompanyTicker
    Dianthus Therapeutics Inc.DNTH
    Regencell Bioscience Holdings LtdRGC
    LivaNova PLCLIVN
    Premier IncPINC
    Heartflow, Inc. Common StockHTFL
    Adaptive Biotechnologies CorpADPT
    Integer Holdings CorpITGR
    Indivior PLC Ordinary SharesINDV

    Sector: Healthcare

    ICUI Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    3
    Buy
    4
    Hold
    1
    Sell
    0
    Strong Sell
    0

    ICUI Bull Case vs Bear Case

    Bull case

    • ICUI beat EPS estimates in 100.0% of its last 8 reported quarters.
    • 87.5% of ICUI's analyst ratings are Buy or Strong Buy.

    ICUI Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    31.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $2.15
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    6 up, 1 down

    Frequently Asked Questions About ICUI

    Does ICUI pay dividends?

    ICU Medical Inc (ICUI) does not currently pay a regular dividend.

    What is ICUI's P/E ratio?

    ICU Medical Inc has a price-to-earnings (P/E) ratio of 20.54.

    What is ICUI's market cap?

    ICU Medical Inc (ICUI) has a market capitalization of $4.08B with a current stock price of $162.69.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In